Literature DB >> 6331343

Mouse hepatitis virus strain--related patterns of tissue tropism in suckling mice.

S W Barthold, A L Smith.   

Abstract

The pattern of tissue tropism for several prototype and uncharacterized strains of mouse hepatitis virus (MHV) was studied by intranasal inoculation of each virus strain into groups of neonatal Swiss mice under otherwise identical conditions. Mice were killed at intervals up to 18 days after inoculation, and their tissues were examined for the presence of MHV antigen by indirect immunofluorescence. Two patterns of infection were apparent. Prototype MHV strains 1, 3, A59, JHM, S and uncharacterized MHV strains Tettnang and wt-1 produced a respiratory pattern, in which nose and lung were consistently involved with dissemination to other organs in a vascular distribution. Pulmonary vascular endothelium and alveolar septal cells, but not airway epithelium, were infected. An enteric pattern was observed with MHV-Y and wt-2 in which MHV antigen was largely restricted to the nose and bowel, with limited dissemination to other abdominal organs but not lung. Intestinal lesions in these mice were severe compared to those manifesting the respiratory pattern of infection. These results indicate that, like coronaviruses of other species, different strains of MHV possess different primary and secondary organotropisms following a natural route of inoculation in a susceptible host.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331343      PMCID: PMC7086666          DOI: 10.1007/bf01309300

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  33 in total

1.  Pulmonary vascular lesions in nude mice persistently infected with mouse hepatitis virus.

Authors:  T Furuta; Y Goto; T Tamura; C Kai; K Ueda
Journal:  Jpn J Exp Med       Date:  1979-12

2.  Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice.

Authors:  L Schindler; H Engler; H Kirchner
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  Epizootic coronaviral typhlocolitis in suckling mice.

Authors:  S W Barthold; A L Smith; P F Lord; P N Bhatt; R O Jacoby; A J Main
Journal:  Lab Anim Sci       Date:  1982-08

4.  New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice.

Authors:  J C Hierholzer; J R Broderson; F A Murphy
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

5.  Influence of the mouse hepatitis virus (MHV) infection on the growth of human tumors in the athymic mouse.

Authors:  A P Kyriazis; L DiPersio; J G Michael; A J Pesce
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

6.  Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation.

Authors:  S W Barthold; A L Smith
Journal:  Lab Anim Sci       Date:  1983-08

7.  Murine coronaviruses: the histopathology of disease induced by intranasal inoculation.

Authors:  P Carthew; S Sparrow
Journal:  Res Vet Sci       Date:  1981-05       Impact factor: 2.534

8.  Viral hepatitis associated with transplantable mouse leukemia. I. Acute hepatic manifestations following treatment with urethane or methylformamide.

Authors:  H BRAUNSTEINER; C FRIEND
Journal:  J Exp Med       Date:  1954-12-01       Impact factor: 14.307

9.  A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin.

Authors:  F S CHEEVER; J B DANIELS
Journal:  J Exp Med       Date:  1949-09       Impact factor: 14.307

10.  Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures.

Authors:  M E Dubois-Dalcq; E W Doller; M V Haspel; K V Holmes
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

View more
  29 in total

1.  Monoclonal antibody solution hybridization assay for detection of mouse hepatitis virus infection.

Authors:  D B Casebolt; C B Stephensen
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Brief report.

Authors:  J Lecomte; V Cainelli-Gebara; G Mercier; S Mansour; P J Talbot; G Lussier; D Oth
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Detection of rodent coronaviruses in tissues and cell cultures by using polymerase chain reaction.

Authors:  F R Homberger; A L Smith; S W Barthold
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

4.  Virus strain specificity of challenge immunity to coronavirus.

Authors:  S W Barthold; A L Smith
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.

Authors:  S W Barthold; D S Beck; A L Smith
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues.

Authors:  J F Boyle; D G Weismiller; K V Holmes
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

7.  Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion.

Authors:  L S Sturman; C S Ricard; K V Holmes
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Prevention of murine norovirus infection in neonatal mice by fostering.

Authors:  Susan R Compton
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

9.  Genetic restriction of murine hepatitis virus type 3 expression in liver and brain: comparative study in BALB/c and C3H mice by immunochemistry and hybridization in situ.

Authors:  D Décimo; O Boespflug; M Meunier-Rotival; M Hadchouel; M Tardieu
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice.

Authors:  C Godfraind; K V Holmes; J P Coutelier
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.